The potency of Cupressus sempervirens and Eucalyptus globulus Essential Oils Against Antibiotic-Resistant Escherichia coli and Mammaliicoccus sciuri from Diseased Animals in Tunisia
Current Microbiology · 2025
DOI: 10.1007/s00284-024-03981-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2025. Verfasst von Sana Dhaouadi und 7 weiteren Autor:innen. Beteiligte Einrichtung: ISBST, BVBGR-LR11ES31, Biotechpole Sidi Thabet, University of Manouba, 2020, Ariana, Tunisia. Hauptthemen laut MEDLINE: Eucalyptus, Oils, Volatile, Escherichia coli, Anti-Bacterial Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: ANPR.
Abstract (Originalsprache)
This study aimed to investigate the antibacterial activity of essential oils from Cupressus sempervirens (CSEO) and Eucalyptus globulus (EGEO) against clinical isolates of colistin-resistant E. coli and methicillin-resistant M. sciuri recovered from diseased food-producing animals in Tunisia. The chemical compositions of both essential oils were analyzed using Gas chromatography-mass spectrometry (GC-MS). Antibacterial activity was determined through disk diffusion and microdilution assays, while the fractional inhibitory concentration index (FICI) was used to measure the synergistic effect of CSEO and colistin. The major constituents of CSEO were α-pinene (59.03%), δ-3 Carene (21.48%), D-limonene (5.62%) and α-thujene (3.08%), while EGEO contained eucalyptol (52.1%), α-pinene (26.51%), γ-terpinene (4.81%) and D-limonene (3.54%). The inhibition zone diameters (IZDs) against E. coli and M. sciuri ranged from 6 to 29 mm for CSEO and 9.3 to 28.6 mm for EGEO. Minimum inhibitory concentrations (MICs) showed a range of 4 to 512 µg/mL for CSEO against M. sciuri and 2 to 426.66 µg/mL for EGEO. For E. coli, MICs ranged from 170.66 to 512 µg/mL for CSEO and 53.33 to 512 µg/mL for EGEO. The checkerboard test demonstrated a synergistic effect between CSEO and colistin against two colistin-resistant E. coli isolates, with FICI 3- to 32-fold lower than the MICs of the individual compounds. This study highlights the potency of essential oils from CSEO and EGEO against antibiotic-resistant M. sciuri and E. coli strains from animals in Tunisia and provides evidence of the synergistic effect between CSEO and colistin against clinically relevant colistin-resistant E. coli isolates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ISBST, BVBGR-LR11ES31, Biotechpole Sidi Thabet, University of Manouba, 2020, Ariana, Tunisia.
- Institut Supérieur de Biotechnologie de Sidi Thabet, University of Manouba, Biotechpole Sidi Thabet, 2020, Ariana, Tunisia.
- MEDIVET, Immeuble Les Mimosas, 159 Avenue de L'UMA, 2036, La Soukra, Tunisia.
- ISBST, BVBGR-LR11ES31, Biotechpole Sidi Thabet, University of Manouba, 2020, Ariana, Tunisia. ramzi.b.landolsi@gmail.com.
Förderung
- ANPR
Zitieren
APA
Dhaouadi, S., Ghorbel, S. K. B., Bouglita, W., Chaari, S., Dhifi, W., Khrouf, R., Cherif, A., & Elandoulsi, R. B. (2025). The potency of Cupressus sempervirens and Eucalyptus globulus Essential Oils Against Antibiotic-Resistant Escherichia coli and Mammaliicoccus sciuri from Diseased Animals in Tunisia. Current Microbiology. https://doi.org/10.1007/s00284-024-03981-6
Vancouver
Dhaouadi S, Ghorbel SKB, Bouglita W, Chaari S, Dhifi W, Khrouf R, et al. The potency of Cupressus sempervirens and Eucalyptus globulus Essential Oils Against Antibiotic-Resistant Escherichia coli and Mammaliicoccus sciuri from Diseased Animals in Tunisia. Current Microbiology. 2025. doi:10.1007/s00284-024-03981-6
BibTeX
@article{Dhaouadi2025,
author = {Dhaouadi, Sana and Ghorbel, Salma Kloula Ben and Bouglita, Wafa and Chaari, Soufiene and Dhifi, Wissal and Khrouf, Rim and Cherif, Ameur and Elandoulsi, Ramzi Boubaker},
title = {The potency of Cupressus sempervirens and Eucalyptus globulus Essential Oils Against Antibiotic-Resistant Escherichia coli and Mammaliicoccus sciuri from Diseased Animals in Tunisia},
journal = {Current Microbiology},
year = {2025},
doi = {10.1007/s00284-024-03981-6}
}
EUVIMED